Panel: Digital Dosing: Technology & Innovation Powering Psychedelics
Dedicated to innovation, Kathryn believes in getting good science out of the lab – and into people’s lives. Experienced in early-stage tech commercialization, Kathryn joined the University of Pittsburgh research team in 2016 to raise funding for clinical research on the Apollo discovery. As CEO, Kathryn has raised millions and built a highly-skilled collaboration of physicians, researchers, engineers, and designers to transform the Apollo technology from a futuristic concept into a simple but powerful tool. Kathryn has spoken on innovation, leadership and the nexus of technology and health at universities and conferences around the world . Raised in upstate New York, Kathryn holds a B.A. from Smith College and a Master of Public Administration, with a focus on behavioral economics and finance, from the Rockefeller College of Public Affairs and Policy. She and her co-founder, Dr. David Rabin MD, PhD, are happily married, and split their time between New York, San Francisco and Pittsburgh, PA.